Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Promisia HealthcareNZSE:PHL 33 Median PS Value is NZ$1.48 as of Jul. 21, 2026, which is 100% below its 10-year median of 0.19. GuruFocus rates NZSE:PHL with a GF Score™ of 33/100 and a GF Value™ of NZ$0.42 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 262 Healthcare Providers & Services companies, Promisia Healthcare ranks better than 80.53% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Promisia Healthcare's Median PS Value or its related term are showing as below:
NZSE:PHL'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.07 Med: 0.19 Max: 0.4
Current: 0.4
During the past 13 years, the highest Price to Median PS Value of Promisia Healthcare was 0.40. The lowest was 0.07. And the median was 0.19.
NZSE:PHL's Price-to-Median-PS-Value is ranked better than 80.53% of 262
companies
in the Healthcare Providers & Services industry
Industry Median: 0.71
vs NZSE:PHL: 0.40
Promisia Healthcare (NZSE:PHL) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Promisia Healthcare's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.59
/
1.48
=
0.40
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Promisia Healthcare Median PS Value Related Terms
Promisia Healthcare Median PS Value Historical Data
* Premium members only.
The historical data trend for Promisia Healthcare's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NZSE:PHL vs HCA, THC, DVA: Median PS Value Comparison
For the Medical Care Facilities subindustry, Promisia Healthcare's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Promisia Healthcare Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Promisia Healthcare's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Promisia Healthcare's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 1.5385.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Promisia Healthcare's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was NZ$0.962.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Promisia Healthcare (NZSE:PHL) has a Median PS Value of NZ$1.48 as of Jul. 21, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Promisia Healthcare and its competitors. This is 679% above median its historical median of 0.19. Over the past decade, Promisia Healthcare's Median PS Value has ranged from 0.07 to 0.40. According to the industry distribution chart, Promisia Healthcare ranks #51 out of 262 companies in the Healthcare Providers & Services industry, placing it in the top 19.5%.
Is Promisia Healthcare's Median PS Value too high?
Promisia Healthcare's current Median PS Value of NZ$1.48 is 679% above median its 10-year median of 0.19. Over the past 10 years, this metric has ranged from a low of 0.07 to a high of 0.40. Based on the distribution chart, Promisia Healthcare ranks #51 out of 262 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Promisia Healthcare has a GF Score™ of 33/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Promisia Healthcare's Median PS Value compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Promisia Healthcare ranks #51 out of 262 companies for Median PS Value. This places Promisia Healthcare in the top 20% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.71. Historically, Promisia Healthcare's own Median PS Value has ranged from 0.07 to 0.40 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.71, based on 262 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Promisia Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Promisia Healthcare's current Median PS Value is NZ$1.48, which is 679% above median its own 10-year median of 0.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Promisia Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Promisia Healthcare (NZSE:PHL) is currently considered Significantly Overvalued. The stock's GF Value™ is NZ$0.42, compared to a current price of NZ$0.59 — trading 40.5% above its estimated fair value. The current Median PS Value is NZ$1.48, which is 679% above median its 10-year median of 0.19. Promisia Healthcare's overall GF Score™ is 33/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Promisia Healthcare (NZSE:PHL), the current Median PS Value is NZ$1.48 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Promisia Healthcare (NZSE:PHL) Overvalued in 2026?
Based on GuruFocus' analysis, Promisia Healthcare stock appears to be overvalued.
The current stock price of NZ$0.59 is trading 40.5% above its estimated GF Value™ of NZ$0.42.
GuruFocus considers Promisia Healthcare to be Significantly Overvalued.
Key valuation signals for NZSE:PHL:
Median PS Value: NZ$1.48 (679% above median its 10-year median of 0.19)
GF Value™: NZ$0.42 vs. price of NZ$0.59 (40.5% above fair value)
No single metric tells the full story. See the NZSE:PHL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Promisia Healthcare Ltd is engaged in the provision of aged care in New Zealand. The company's services include Resthome Care, Hospital (Continuing) Care, Respite (Short Term) Care, Young Disabled Care, Dementia Care, and others. The Group operates in one operating segment: the provision of aged care in New Zealand.
33GF Score
Get the complete analysis for NZSE:PHL
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NZSE:PHL has been successfully added to your 
